threonine has been researched along with Carcinoma, Neuroendocrine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, SM; Busaidy, NL; Chmielecki, J; Elvin, JA; Erlich, RL; Heilmann, AM; Khan, SA; Lipson, D; Miller, VA; Murthy, R; Nangia, C; Ross, JS; Shah, MH; Sherman, SI; Stephens, PJ; Subbiah, I; Subbiah, V; Sun, JX; Vergilio, JA; Wang, K; Yelensky, R | 1 |
Astudillo-de la Vega, H; Garcia, MG; Guadarrama-Orozco, JA; Lino-Silva, LS; Lopez-YaƱez, A; Meneses-Garcia, A; Ruiz-Garcia, E; Torres, JAP; Vidal-Millan, S | 1 |
Cote, G; Grubbs, EG; Habra, MA; Hu, MI; Jasim, S; Jimenez, C; Rich, TA; Waguespack, SG; Ying, AK | 1 |
3 other study(ies) available for threonine and Carcinoma, Neuroendocrine
Article | Year |
---|---|
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma.
Topics: Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Drug Resistance, Neoplasm; Everolimus; Female; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Gene Amplification; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Methionine; Middle Aged; Molecular Targeted Therapy; Mutation; Piperidines; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Pyridines; Quinazolines; Threonine; Thyroid Neoplasms | 2016 |
Search of the p.M918T Mutation in the RET Oncogene in Mexican Adult Patients with Medullary Thyroid Carcinoma.
Topics: Adolescent; Adult; Amino Acid Substitution; Carcinoma, Neuroendocrine; DNA Mutational Analysis; Female; Gene Frequency; Humans; Male; Methionine; Mexico; Middle Aged; Mutation, Missense; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Threonine; Thyroid Neoplasms; Young Adult | 2017 |
Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Alanine; Carcinoma, Neuroendocrine; Female; Germ-Line Mutation; Humans; Methionine; Multiple Endocrine Neoplasia Type 2b; Phenylalanine; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Risk Factors; Threonine; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2011 |